2; 348(9036):1196-1201.
Paul RE, Packer MJ, Walmsley M, Lagog M, Ranford-Cartwright LC, Paru R, et al.
Mating patterns in malaria parasite populations of Papua New Guinea.
Science. 1995 Sep 22; 269(5231):1709-1711.
Peel SA. The ABC transporter genes of Plasmodium falciparum and drug resistance.
Drug Resist Updat. 2001 Feb; 4(1):66-74.
Peters W. Chemotherapy of malaria and the host-parasite interaction. Indian J
Malariol. 1984 Jun; 21(1):7-16.
Peters W. The problem of drug resistance in malaria. Parasitology. 1985 Apr; 90 ( Pt
4):705-715.
Povoa MM, Machado RL, Segura MN, Vianna GM, Vasconcelos AS, Conn JE.
Infectivity of malaria vector mosquitoes: correlation of positivity between
ELISA and PCR-ELISA tests. Trans R Soc Trop Med Hyg. 2000 Jan-Feb;
94(1):106-107.
Pradines B, Fusai T, Daries W, Laloge V, Rogier C, Millet P, et al. Ferrocene-
chloroquine analogues as antimalarial agents: in vitro activity of
ferrochloroquine against 103 Gabonese isolates of Plasmodium falciparum. J
Antimicrob Chemother. 2001 Aug; 48(2):179-184.
Pradines B, Hovette P, Fusai T, Atanda HL, Baret E, Cheval P, et al. Prevalence of in
vitro resistance to eleven standard or new antimalarial drugs among
Plasmodium falciparum isolates from Pointe-Noire, Republic of the Congo. J
Clin Microbiol. 2006 Jul; 44(7):2404-2408.
Price RN, Tjitra E, Guerra CA, Yeung S, White NJ, Anstey NM. Vivax malaria:
neglected and not benign. Am J Trop Med Hyg. 2007 Dec; 77(6 Suppl):79-87.
Price RN, Uhlemann AC, Brockman A, McGready R, Ashley E, Phaipun L, et al.
Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene
copy number. Lancet. 2004 Jul 31-Aug 6; 364(9432):438-447.
Raj DK, Mu J, Jiang H, Kabat J, Singh S, Sullivan M, et al. Disruption of a
Plasmodium falciparum Multidrug Resistance-associated Protein (PfMRP)
Alters Its Fitness and Transport of Antimalarial Drugs and Glutathione. J Biol
Chem. 2009 Mar 20; 284(12):7687-7696.
Reed MB, Saliba KJ, Caruana SR, Kirk K, Cowman AF. Pgh1 modulates sensitivity
and resistance to multiple antimalarials in Plasmodium falciparum. Nature.
2000 Feb 24; 403(6772):906-909.
Ringwald P, Bickii J, Basco LK. Amodiaquine as the first-line treatment of malaria in
Yaounde, Cameroon: presumptive evidence from activity in vitro and cross-
resistance patterns. Trans R Soc Trop Med Hyg. 1998 Mar-Apr; 92(2):212-
213.
Rohrbach P, Sanchez CP, Hayton K, Friedrich O, Patel J, Sidhu AB, et al. Genetic
linkage of pfmdr1 with food vacuolar solute import in Plasmodium falciparum.
Embo J. 2006 Jul 12; 25(13):3000-3011.
Rosario VE, Hall, R., Walliker, D., Beale, G.H. Persistence of drug-resistant malaria parasites. Lancet. 1978; 1:186-187.
Ruetz S, Delling U, Brault M, Schurr E, Gros P. The pfmdr1 gene of Plasmodium
falciparum confers cellular resistance to antimalarial drugs in yeast cells. Proc
Natl Acad Sci U S A. 1996 Sep 3; 93(18):9942-9947.
Rungsihirunrat K, Chaijareonkul W, Seugorn A, Na-Bangchang K, Thaithong S.
Association between chloroquine resistance phenotypes and point mutations
in pfcrt and pfmdr1 in Plasmodium falciparum isolates from Thailand. Acta
Trop. 2009 Jan; 109(1):37-40.
Sachs J, Malaney P. The economic and social burden of malaria. Nature. 2002 Feb